Evaluation of a Probiotic On Anxiety and Stress in Healthy Adults Sensible to Daily Stress
BIOSTRESS
Evaluation Des Effets Anti-Stress D'un Probiotique Nomme PROBIOSTICK® Sur Des Sujets Humains Volontaires Sains Sensibles Au Stress De La Vie Quotidienne
1 other identifier
interventional
66
1 country
1
Brief Summary
The purpose of the the study is to determine if PROBIOSTICK® decrease stress and anxiety of people sensible to daily stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started Dec 2008
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 8, 2008
CompletedFirst Posted
Study publicly available on registry
December 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedApril 24, 2009
April 1, 2009
4 months
December 8, 2008
April 23, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SCL 90 questionnaire
day 0 and day 30
Secondary Outcomes (1)
Stress perçu, coping de vitaliano, hospital anxiety and depression questionnaires and urinary cortisol measurement
day-14 ; day 0 and day 30
Study Arms (2)
2
PLACEBO COMPARATOREvery morning subjects will consume a stick of placebo during 30 days
1
EXPERIMENTALEvery morning subjects will consume a stick of PROBIOSTICK® during 30 days
Interventions
Every morning subjects will consume a stick of PROBIOSTICK® during 30 days
Every morning subjects will consume a stick of placebo during 30 days
Eligibility Criteria
You may qualify if:
- Caucasian healthy men or women
- Age 30-60 years
- Hospital anxiety and depression score equal or below 12 and above 4
- Standard safety biology
You may not qualify if:
- HAD A results above 12 and below 4
- HAD D results above 12
- Neurologic or psychiatric pathology
- Consumption of psychotropic
- High level of caffeine consumption
- Any important chronic pathology
- Drugs wich impairs concentration, anxiety and stress
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Biofortis
Nantes, 44200, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 8, 2008
First Posted
December 11, 2008
Study Start
December 1, 2008
Primary Completion
April 1, 2009
Study Completion
April 1, 2009
Last Updated
April 24, 2009
Record last verified: 2009-04